Company Filing History:
Years Active: 2004
Title: Mary Katherine Lawless: Innovator in Anti-Retroviral Research
Introduction
Mary Katherine Lawless is a notable inventor based in Raleigh, NC (US). She has made significant contributions to the field of anti-retroviral research, particularly in the development of methods and compositions aimed at inhibiting HIV transmission. Her work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
Mary Katherine Lawless holds a patent for "Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission." This invention relates to peptides that exhibit potent anti-retroviral activity. The peptides include the DP178 (SEQ ID:1) peptide, which corresponds to amino acids 638 to 673 of the HIV-1 gp41 protein. The invention also encompasses fragments, analogs, and homologs of DP178. Furthermore, it details the uses of these peptides as inhibitors of human and non-human retroviral transmission, especially HIV, to uninfected cells.
Career Highlights
Mary Katherine Lawless is associated with Trimeris, Inc., where she continues her research and development efforts. Her work at this company highlights her commitment to advancing medical science and improving treatment options for those affected by retroviruses.
Collaborations
Some of her notable coworkers include Peter W. Jeffs and John William Lackey. Their collaboration has likely contributed to the innovative research and development efforts at Trimeris, Inc.
Conclusion
Mary Katherine Lawless is a pioneering inventor whose work in anti-retroviral research is making a significant difference in the fight against HIV. Her contributions through her patent and collaboration with esteemed colleagues underscore her dedication to advancing healthcare solutions.